Discover more information about HAEGARDA® (C1 Esterase Inhibitor (Human)), used for the treatment of HAE attacks including product information, mechanism of action, educational …

Discover scientific information and resources for healthcare professionals related to CSL Behring medicines.

CSL Behring’s strong commitment to living our Values has guided us for many decades. Our Values have been fundamental to our success -- helping us to save lives, protect the health of …

Complete Response Reevaluate diagnosis ©2022 CSL Behring LLC. USA-HIZ-0521 NOV22 Received: 16 May 2021 Revised: 27 May 2021 Accepted: 28 May 2021

CSL Behring is committed to producing high-quality, safe and effective biotherapies to save lives and improve the quality of life for people with rare and serious medical conditions worldwide.

CSL Behring’s strong commitment to living our Values has guided us for many decades. Our Values have been fundamental to our success -- helping us to save lives, protect the health of …

Reach out to CSL Behring North America Medical Information team via phone, e-mail, or medical information request form to respond to questions.

To report SUSPECTED ADVERSE REACTIONS, contact CSL Behring at 1-866-915-6958 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Find information on your designated North America Medical Affairs Field Medical Representative and schedule an introduction meeting.

To report SUSPECTED ADVERSE REACTIONS, contact the CSL Behring Pharmacovigilance Department at 1-866-915-6958 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.